Viewing Study NCT00973557


Ignite Creation Date: 2025-12-24 @ 6:40 PM
Ignite Modification Date: 2026-03-08 @ 12:25 AM
Study NCT ID: NCT00973557
Status: COMPLETED
Last Update Posted: 2012-02-07
First Post: 2009-09-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function
Sponsor: Cedars-Sinai Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module